The use of medicinal plants in the treatment of mental disorders: An overview

Nwobodo N. N., R. O. Offiah

Abstract


It has been known from the ancient times, spanning hundreds of years of recorded and unrecorded history, that people have used different methods and procedures in treatment of different psychiatric disorders and very often these were medicinal preparations from plants. Numerous scientific discoveries and advent of industrial age gave a big boost to drug development and significantly improved quality of life for psychiatric patients during the last century. Nevertheless, after huge success, joy and relief, evidence has shown that quest for natural medicines faced a lot of disappointment, leading to a poor attitude that resulted to some natural drugs unnecessarily thrown out. On the other hand, there are a huge number of patients that use natural medicinal plants in self-treatment of different psychiatric disorders. It is reported that herbal medicines are used in treating a broad range of psychiatric disorders including anxiety, depression, obsessive-compulsive, affective, bipolar maniac-depressive, psychotic, phobic and somatoform disorders. Currently, there is insufficient clinical evidence for the use of many herbal medicines in psychiatric disorders.  Significant and urgent research are required to address current issues in herbal psychotherapy such as herbal safety, future areas of application, the relationship of herbal medicine with pharmaceuticals and the potential prescriptive integration of phytomedicines with synthetic psychotropic medicines.


Keywords


Drug-herb interaction, herbal medicine, medicinal plants, mental disorder, phytomedicine and phytotherapy

Full Text:

PDF

References


. World Health Organization. Atlas: Mental Health Resources in the World, 2001. World Health Organization, Geneva.

. Mullen P.E. Mental Health and the Law, 2010. McGraw Hills Publishers. USA.

. United Nations International Children’s Emergency Fund and World Health Organization. Collaborative Study of Mental Health Needs Across the World, 2009. World Bank Project.

. Schmidt C.W. Environment connects: A deeper look into mental illness. Environmental Health Perspectives, 2007. 115(8): A404-10.

. Desjarlais R., Eisenberg L., Good B., Kleinman A. World mental health: problems and priorities in low income countries, 1995. Oxford University Press, New York.

. Porter R. Madness: A brief history, 2002. Oxford University Press, Oxford.

. World Health Organization. The Mental Health Context, 2003. World Health Organization, Geneva.

. Corrigan P.W. Mental health stigma as social attribution: Implications for research methods and attitude change, 2000. American Psychological Association. D12: 48-67.

. Corrigan P.W., Watson A.C. Understanding the impact of stigma on people with mental illness. World Psychiatry, 2002. 1: 16-20.

. Ahmed S., Sun Z., Nazar H. Employees’ health: Work behaviour and organizational performance. Int. J. Educ. Res, 2015. 3(1): 475-84.

. Link B.G., Phelan J.C., Bresnahan M., Stueve A., Pescosolido B.A. Public conceptions of mental illness: labels, causes, dangerous and social distance. Am. J. Public Health, 1999. 89(9): 1328-1333.

. Ojua T.A., Omono C. African sacrificial ceremonies and issues in socio-cultural development. Br. J. Arts Soc. Dev, 2012. 4(1): 26-34.

. Gureje O., Lasebikan V.O., Ephraim-Oluwanuga O., Olley B.O., Kola L (2005). Community study of knowledge and attitude to mental illness in Nigeria. Br. J. Psych, 2005. 186: 436-41.

. Oluwole S. ‘On the existence of witches’. In A. Mosley (Ed.), African Philosophy, 1995. Prentice Hall, New Jersey.

. Gaske G.G., Stewart J.R. Stigmatic and mythical thinking: Barriers to vocational rehabilitation services of persons with severe mental illness. J. Rehabilitation, 1999. 65(4): 4-9.

. Kayombo E.J., Mahunnah R.L.A., Uiso F.C. Prospects and challenges of medicinal plants conservation and traditional medicine in Tanzania. Anthropol., 2013. 1:108. doi:10.4172/2332-0915.1000108.

. Zuckerman D., Debenham K., Moore K. The ADA and People with Mental Illness: A Resource Manual for Employers, 1993. The National Mental Health Association, 1021 Prince Street, Alexandria, VA 22314-2971, (703)684-7722.

. Flausino O.A. Jr, Pereira A.M., da Silva Bolzani V., Nunes-de-Souza R.L. Effects of erythrinian alkaloids isolated from Erythrina mulungu (Papilionaceae) in mice contributed to animal models of anxiety. Biol Pharm Bull, 2007. 30(2): 375-78.

. Santos Rosa D., Faggion S.A., Gavin A.S., Anderson de Souza M., Fachim H.A., Ferreira dos Santos W., Soares Pereira A.M., Cunha A.O., Beleboni R.O. Erysothrine, an alkaloid extracted from flowers of Erythrina mulungu: evaluating its anticonvulsant and anxiolytic potential. Epilepsy Behav, 2012 . 23(3): 205-12. doi: 10.1016/j.yebeh.2012.01.003.

. Kathryn E. Wellen, Gokhan S. Hotamisligil. Inflammation, stress, and diabetes. J Clin Invest, 2005. 115(5):1111-19. doi:10.1172/JCI25102.

. Rogers J. The inflammatory response in Alzheimer’s disease. J Periodontal, 2008. 79(8 Suppl): 1535-42. doi: 10.1902/jop.2008.080171.

. Yadav S.K.., Prakash J., Chouhan S., Westfall S., Verma M., Singh T.D., Singh S.P. Comparison of the neuroprotective potential of Mucuna pruriens seed extract with estrogen in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced PD mice model. Neurochem Int, 2013. 11: 65C:1-13. doi: 10.1016/j.neuint.2013.12.001.

. Lee Y., Jung J.C., Jang S., Kim J., Ali Z., Khan I.A., Oh S. Anti-inflammatory and neuroprotective effects of constituents isolated from Rhodiola rosea. Evidence Based Complement Alternative Med, 2013. Doi:10.1155/2013/514049.

. Olsson E.M., von Schele B., Panossian A.G. A randomised, double-blind, placebo-controlled, parallel-group study of the standardised extract shr-5 of the roots of Rhodiola rosea in the treatment of subjects with stress-related fatigue. Planta Med, 2009. 75(2): 105-12.doi:10.1055/s-0028-1088346.

. Jiang J.G.I., Huang X.J., Chen J., Lin Q.S. Comparison of the sedative and hypnotic effects of flavonoids, saponins and polysaccharides extracted from Semen Ziziphus jujube. Nat Prod Res, 2007. 21(4): 310-20.

. Ngan A., Conduit R. A double-blind, placebo-controlled investigation of the effects of Passiflora incarnata (passionflower) herbal tea on subjective sleep quality. Phytother Res, 2011. 25(8): 1153-9.doi:10.1002/ptr.3400.

. Brock C.I., Whitehouse J., Tewfik I., Towell T. American Skullcap (Scutellaria lateriflora): a randomised, double-blind placebo-controlled crossover study of its effects on mood in healthy volunteers. Phytother Res, 2014. 28(5): 692-98, doi: 10.1002/ptr.5044.

. Lohani M., Ahuja M., Buabeid M.A., Dean S., Dennis S., Suppiramaniam V., Kemppainen B., Dhanasekaran M. (2013). Anti-oxidative and DNA protecting effects of flavonoids-rich Scutellaria lateriflora. Nat Prod Commun, 2013. 8(10):1415-18.

. Connor K.M., Davidson J.R., Churchill L.E. Adverse-effect profile of kava. CNS Spectr, 2001. 6(10): 848: 850-53.

. Hausenblas H.A.I., Saha D., Dubyak P.J., Anton S.D. Saffron (Crocus sativus) and major depressive disorder: a meta-analysis of randomized clinical trials. J Integr Med, 2013. 11(6): 377-83. doi: 10.3736/jintegrmed2013056.

. Offiah R.O., Salawu O.A., Anuka J.A., Magaji M.G., Tijani A.Y. Behavioural studies on the methanolic stem bark extract of Ficus Ingens (Miquel) Miquel (Moraceae) in mice. African Journal of Pharmaceutical Research & Development, 2015. 7(1):11-18.

. Offiah R.O., Nwobodo N.N., Salawu O.A.. Anuka J.A. Evaluation of anxiolytic and anticonvulsant properties of methanolic stem bark extract of Ficus Ingens (Miquel) Miquel (Moraceae) in mice and chicks. International Journal of Biological & Pharmaceutical Research, 2016. 7(5): 251-56.

. Miller L.G. Herbal medicinals: selected clinical considerations focusing on known or potential drug-herb interactions. Arch Intern Med, 1998. 158: 2200-11.

. Richards J.S. Overview of herbal supplements. Elite Continuing Education, 2013. pp. 46-62.

. Jappe U., Franke I., Reinhold D., Gollnick H.P. Sebotropic drug reaction resulting from kava-kava extract therapy: a new entity? J Am Acad Dermatol, 1998. 38:104–06.




DOI: http://dx.doi.org/10.7439/ijpp.v7i3.4264

Article Metrics

Metrics Loading ...

Metrics powered by PLOS ALM

Refbacks

  • There are currently no refbacks.




Copyright (c) 2017 International Journal of Phytopharmacy

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.